80% of patients with a hereditary risk for cancer are unaware of their risk. Scalable approaches to identifying patients who have a hereditary risk for cancer are needed in order to enable prevention and early detection of cancer.
RISE Risk Assessment Module: Hereditary Cancer is a patient-administered digital tool that has been clinically validated to identify individuals who may benefit from cancer genetic testing.
Created by genetics experts, the RISE Risk Assessment Module: Hereditary Cancer collects and analyzes family and personal health history to determine if a patient meets genetic testing criteria for hereditary cancer.
completion
rate
minutes on average
to complete
of patients met
testing criteria
1 National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. J Clin Oncol. 2017
2 Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011
